IL44791A - Cephalosporin cleavage process - Google Patents

Cephalosporin cleavage process

Info

Publication number
IL44791A
IL44791A IL44791A IL4479174A IL44791A IL 44791 A IL44791 A IL 44791A IL 44791 A IL44791 A IL 44791A IL 4479174 A IL4479174 A IL 4479174A IL 44791 A IL44791 A IL 44791A
Authority
IL
Israel
Prior art keywords
acid
cephalosporin
hydrazine
treatment
reacted
Prior art date
Application number
IL44791A
Other versions
IL44791A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL44791A0 publication Critical patent/IL44791A0/en
Publication of IL44791A publication Critical patent/IL44791A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/187-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Claims (12)

■A: What we claim is :
1. A process for cleaving the amic acid function ΐ:ι of a 7- (amic acid) cephalosporin having the formula 0 COO R I in which R and R are hydrogen, or R and R taken together a a with the carbon atoms to which they are attached represent an ortho-phenylene ring; R^ is a carboxy protecting group; and 2 is hydrogen, acetoxy, methoxy, methylthio, (5-methyl-l , 3 , 4- thiadiazol-2-yl ) thio , or ( l-methyl-lH-tetrazol-5-yl ) thio ; which comprises (1) reacting said 7- (amic acid) cephalosporin with an alkyl chloroformate in the presence of a tertiary amine to form the corresponding mixed anhydride having the formula 0 in which R, is an alkyl group having from 1 to 4 carbon atoms; X- 3996 - 35 - (2) reacting the product mixture from the aforementioned chlorofprmate treatment with a hydrazine of the formula R3HNNHR4 in which ^ and R^ independently are hydrogen or methyl; and (3) a) reacting the reaction mixture from the aforementioned hydrazine treatment with an acyl halide to produce the corresponding 7-acylamido cephalosporin; or b) when at least one of R3 and ^ is methyl, recovering the corresponding 7-amino cephalosporin from the reaction 10 mixture of the aforementioned hydrazine treatment; or c) when R^ and R^ are hydrogen, heating the reaction mixture from the aforementioned hydrazine treatment to a temperature of from about 50 °C. to about 100 °C. to produce the corresponding 7-amino cephalosporin; or d) when R^ and R^ are hydrogen, reacting the reaction mixture from the aforementioned hydrazine treatment with acid to produce the corresponding 7-amino cephalosporin in the form of its acid addition salt.
2. Process of claim 1, in which the reaction 20 mixture from the hydrazine treatment is reacted with an acyl halide to produce the corresponding 7-acylamido cephalosporin.
3. Process of claim 1, in which the product mixture from the chloroformate treatment is reacted with a hydrazine in which at least one of R^ and R^ is methyl, and the 7-amino cephalosporin is recovered from the reaction mixture.
4. Process of claim 1, in which the product mixture from the chloroformate treatment is reacted with a hydrazine in which R_ and R. are hydrogen, and the resulting X-3996 -36- reaction mixture is heated to a temperature of from about 50°C. to about 100°C. to produce the 7-amino cephalosporin.
5. Process of claim 1, in which the product mixture from the chloroformate treatment is reacted with a hydrazine in which R3 and R4 are hydrogen, and the :■-,,->- resulting reaction mixture is reacted with acid to produce the 7-amino cephalosporin in the form of its acid addition sal .
6. Process of any of claims 1 to 5, in which the . 10 amic acid cephalosporin is reacted with an alkyl chloroformate in the presence of a tertiary amine at a temperature of from about -20°C. to about +5°C.
7. Process of any of claims .1 to 6, in which the alkyl chloroformate is ethyl chloroformate .
8. Process of claim 5, in which the product mixture from the chloroformate treatment is first reacted with up to 1 equivalent of a hydrazine in which and are hydrogen per equivalent of the amic acid at a temperature of from about -10 °C. to about room temperature for from about 1 to about 20 10 minutes, and the resulting reaction mixture is reacted with from about 1 to about 2 equivalents of an acid selected from the group consisting of hydrochloric acid, hydrobromic acid, phosphoric acid, p-toluenesulfonic acid, methanesulfonic acid, and sulfuric acid per equivalent of the original amic ... acid for about 5 to about 10 minutes to produce the corresponding 7-amino cephalosporin in the form of its acid addition salt.. X-3996 -37-
9. Process of claim 3, in which the product mixture from the chloroformate treatment is first reacted with up to 1 equivalent of a hydrazine in which at least one of and R4 is methyl per equivalent of the amic acid at a temperature of from about -10 °C. to about room temperature for from about 1 to about 10 minutes to produce the corresponding 7-amino cephalosporin.
10. Process of any of claims 1 to 9 for cleaving the amic acid function of a compound of formula I in which R and R are hydrogen. el
11. Process of any of claims 1 to 9 for cleaving the amic acid function of a compound of formula I in which R and R¾ taken together with the carbon atoms to which they are attached represent an ortho-phenylene ring.
12. A process for cleaving the amic acid function of a 7- (amic acid) cephalosporin substantially as hereinbefore described with particular reference to the examples. S. HOROWITZ & CO. AGENTS FOR APPLICANTS X-3996 -38-
IL44791A 1973-06-18 1974-05-09 Cephalosporin cleavage process IL44791A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US371011A US3905966A (en) 1973-06-18 1973-06-18 Cephalosporin cleavage process

Publications (2)

Publication Number Publication Date
IL44791A0 IL44791A0 (en) 1974-07-31
IL44791A true IL44791A (en) 1976-09-30

Family

ID=23462129

Family Applications (1)

Application Number Title Priority Date Filing Date
IL44791A IL44791A (en) 1973-06-18 1974-05-09 Cephalosporin cleavage process

Country Status (12)

Country Link
US (1) US3905966A (en)
JP (1) JPS61352B2 (en)
BE (1) BE816408A (en)
CA (1) CA1018155A (en)
CH (1) CH601313A5 (en)
DE (1) DE2429166A1 (en)
ES (2) ES427388A1 (en)
FR (1) FR2233328B1 (en)
GB (1) GB1474544A (en)
IE (1) IE39253B1 (en)
IL (1) IL44791A (en)
NL (1) NL7408170A (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001239A (en) * 1973-06-18 1977-01-04 Eli Lilly And Company Cephalosporin cleavage process
US3994888A (en) * 1973-06-18 1976-11-30 Eli Lilly And Company Cephalosporin cleavage process
US4039535A (en) * 1973-12-10 1977-08-02 Eli Lilly And Company 7-[α-(GUANYL-1-UREIDO)PHENYLACETAMIDO]-3-SUBSTITUTED CEPHALOSPORIN ANTIBIOTICS
JPS52124221A (en) * 1976-04-10 1977-10-19 Toshizou Miyai Water tpa with selffclosing valve
US5239069A (en) * 1990-05-14 1993-08-24 Eli Lilly And Company Amino protecting group
US5169945A (en) * 1990-05-14 1992-12-08 Eli Lilly And Company Amino protecting group
CA2041897A1 (en) * 1990-05-14 1991-11-15 Leland Otto Weigel Amino protecting group

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3487074A (en) * 1966-01-14 1969-12-30 Bristol Myers Co Derivatives of 6-amino-3-penamylcarboxylic acid and 7-amino-2,2-dimethyl-cephalosporanic acid
US3487070A (en) * 1966-01-14 1969-12-30 Bristol Myers Co 3-blocked amino-4-sulfhydryl-2-azetidinones
US3769281A (en) * 1970-07-09 1973-10-30 Lilly Co Eli Deblocking process for cephalosporin antibiotics

Also Published As

Publication number Publication date
GB1474544A (en) 1977-05-25
US3905966A (en) 1975-09-16
IE39253B1 (en) 1978-08-30
IL44791A0 (en) 1974-07-31
FR2233328A1 (en) 1975-01-10
ES448016A1 (en) 1977-07-01
NL7408170A (en) 1974-12-20
CH601313A5 (en) 1978-07-14
JPS61352B2 (en) 1986-01-08
FR2233328B1 (en) 1977-10-07
CA1018155A (en) 1977-09-27
DE2429166A1 (en) 1975-01-09
BE816408A (en) 1974-12-17
ES427388A1 (en) 1976-09-16
JPS5036488A (en) 1975-04-05
IE39253L (en) 1974-12-18

Similar Documents

Publication Publication Date Title
IL44791A (en) Cephalosporin cleavage process
ES412859A1 (en) Process for preparing 7-(alpha-hydroxy-alpha-phenyl)acetamido-3-(1-methyl-1h-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid and derivatives thereof
GB1009302A (en) Organic peroxides and a process for preparing them
ATE19631T1 (en) PROCESS FOR THE PREPARATION OF (3S)-3-(((2-AMINO-4-THIAZOLYL)-((1-CARBOXY-1-ME HYLETHOXY)-IMINO)ACETYL)-AMINO)-2-OXO-1-AZETIDINE SULPHONE| URE AND 4- SUBSTITUTED DERIVATIVES.
HUT36799A (en) Process for producing cepheme-carboxylic acid derivatives and pharmaceutical compositions containing them
DE3069173D1 (en) Substituted phenylamino-2-imidazoline-2 derivatives, their acid addition salts, medicaments containing them and process for their preparation
EP0187209A3 (en) Process for the preparation of cephalosporins
KR910009713A (en) 3-fluorosulfonyloxysef-3-m substitution method
SE7600585L (en) PROCEDURE FOR THE PREPARATION OF 7-AMINOCEFALOSPORANIC ACID DERIVATIVES
GB1474545A (en) Penicillin and cephalosporin cleavage process and compounds useful therein
AU723133B2 (en) Process for producing 1-chlorocarbonyl-4-piperidinopiperidine or hydrochloride thereof
KR900018011A (en) Process for preparing acyl cyanide in anhydrous medium
US3763152A (en) Neutral cephalosporin anhydrides
DE69225651T2 (en) USE OF HALOGENATED BETA LACTAMES FOR THE PRODUCTION OF 3-HYDROXYCEPHEM DERIVATIVES
KR100498894B1 (en) Process for producing 1-chlorocarbonyl-4-piperidino- piperidine or hydrochloride thereof
SE7503560L (en)
GR3021336T3 (en) New process for the preparation of 20-oxo, 17-alpha, 21-dihydroxy derivatives of pregnane and new intermediates thereof.
JPS5653684A (en) Production of cephalosporin derivative
JPS55151547A (en) Production of guanidinocapronic ester
JPS54112891A (en) Preparation of 7-substituted aminocephalosporanic acid derivative
ES8106281A1 (en) Preparation of aminosulphonic acids and their derivatives.
GB1043502A (en) New betaines and process for their manufacture
GB1482388A (en) Method of producing 6-beta-amidinopenicillanic acid derivatives
JPS5331628A (en) Isolation and purification of aromatic compounds with monohalogenated side chains
JPS56158790A (en) Preparation of cephalosporin derivative